Ultrasonic Devices Market Analysis | United States | 2017-2023 | MedCore

Ultrasonic Devices Market Analysis | United States | 2017-2023 | MedCore

0

Ultrasonic devices use ultrasonic energy to cut and coagulate tissue. They can complement or replace vessel ligators, hemostatic clips and monopolar electrosurgical instruments. In contrast to devices such as lasers or electrocautery instruments that use heat from electrical energy to cauterize tissue, ultrasonic instruments convert electrical energy to mechanical energy in order to transect tissue. This conversion results in less charred tissue than in operations that use monopolar dissection. Less smoke from reduced tissue charring also benefits surgeons by providing them with a clearer view of the operative field. Depending on the indication, ultrasonic devices have quicker cutting times but slightly inferior vessel sealing capabilities than their direct energy counterparts.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 9/1/2017
  • Pages: 132
  • Type: MedCore

The reposable ultrasonic device market representedthe majority of the total ultrasonic instruments device market. The reposable market is dominated by Ethicon’s line of reposable HARMONIC® products, which have shown strong growth in both unit sales and revenue. Overall, growth in the ultrasonic device market is expected to decrease in magnitude in the coming years as ultrasonic devices reach full market penetration

Ultrasonic devices use ultrasonic energy to cut and coagulate tissue. They can complement or replace vessel ligators, hemostatic clips and monopolar electrosurgical instruments. In contrast to devices such as lasers or electrocautery instruments that use heat from electrical energy to cauterize tissue, ultrasonic instruments convert electrical energy to mechanical energy in order to transect tissue. This conversion results in less charred tissue than in operations that use monopolar dissection. Less smoke from reduced tissue charring also benefits surgeons by providing them with a clearer view of the operative field. Depending on the indication, ultrasonic devices have quicker cutting times but slightly inferior vessel sealing capabilities than their direct energy counterparts.

Segments Covered in This Market

  • Ultrasonic Instrument Device Market (Reusable, Reposable)
  • Ultrasonic Generator Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Ethicon led the U.S. market for ultrasonic devices. The company dominates the market with the HARMONIC® ultrasonic line. This series of reposable devices has allowed Ethicon to lead the reposable ultrasonic segment. Olympus was the only ultrasonic device manufacturer to compete in all three segments of the ultrasonic device market. Medtronic recently released the Sonicision™ cordless ultrasonic dissection device, which is the industry’s first cordless ultrasonic dissection device.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Laparoscopic Devices – MedSuite

Learn More about these product types



The "US Market Report Suite for Laparoscopic Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Covidien
Ethicon
Stryker
Karl Storz
Applied Medical
Olympus
Richard Wolf
ConMed
Bayer
B. Braun Aesculap
CareFusion
C. R. Bard
Apollo Endoscopy
Microline Surgical
Cooper Surgical
Integra LifeSciences (Jarit)
Lina Medical
ReShape Medical
Obalon Therapeautics
Teleflex
Others include: Smith and Nephew, B.Braun/Aesculap, Cooper Surgical, Integra LifeSciences, Karl Storz, Olympus, Richard Wolf, Solos Endoscopy, Stryker, Surgiquest, Teleflex, Blue Endo, Cambridge Endo, Surgical Innovations, Cardinal Health, Bovie Medical, CareFusion, ERBE, Jarit, Megadyne, ThermoFisher, Cousin Biotech, Soring etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link